Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Causes and consequences of microsatellite instability in gastric carcinogenesis
Sérgia Velho1, Maria Sofia Fernandes1, Marina Leite1
1Sérgia Velho, Maria Sofia Fernandes, Marina Leite, Ceu Figueiredo, Raquel Seruca, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, 4200-465 Porto, Portugal.
Abstract:
Loss of DNA mismatch repair (MMR) function, due to somatic or germline epi/genetic alterations of MMR genes leads to the accumulation of numerous mutations across the genome, creating a molecular phenotype known as microsatellite instability (MSI). In gastric cancer (GC), MSI occurs in about 15% to 30% of the cases. This review summarizes the current knowledge on the molecular mechanisms underlying the acquisition of MSI in GC as well as on the clinic, pathologic and molecular consequences of the MSI phenotype. Additionally, current therapeutic strategies for GC and their applicability in the MSI subset are also discussed.
Insights
Microsatellite instability (MSI) arises from DNA mismatch repair (MMR) gene alterations, impacting 15-30% of gastric cancer (GC) cases. This review explores MSI
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- DNA mismatch repair (MMR) gene alterations cause microsatellite instability (MSI).
- MSI is a molecular phenotype characterized by widespread genomic mutations.
- In gastric cancer (GC), MSI is observed in 15-30% of patients.
Purpose of the Study:
- To review the molecular mechanisms of MSI development in GC.
- To summarize the clinical, pathological, and molecular consequences of MSI in GC.
- To discuss current GC therapeutic strategies and their relevance for the MSI subset.
Main Methods:
- Literature review of molecular mechanisms.
- Analysis of clinical and pathological data associated with MSI.
- Evaluation of therapeutic strategies for MSI-GC.
Main Results:
- Detailed explanation of molecular pathways leading to MSI in GC.
- Characterization of the distinct clinicopathological and molecular features of MSI-GC.
- Discussion on the potential and limitations of current therapies in MSI-GC.
Conclusions:
- MSI is a significant molecular subtype of GC with unique characteristics.
- Understanding MSI mechanisms and consequences is crucial for targeted therapies.
- Further research is needed to optimize treatment strategies for MSI-positive GC patients.
Related Concept Videos
Gastritis II: Pathophysiology
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Mutagenicity and Carcinogenicity
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Cancers Originate from Somatic Mutations in a Single Cell

